Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

personalised

UK sets up four e-health research centres

Government-backed consortium will use electronic health records to improve patient care

Novartis day

Novartis signs cancer immunotherapy deal with Penn

R&D alliance with the University of Pennsylvania will focus on novel T-cell immunotherapies

Ex-Bayer R&D chief joins Gemmus Pharma board

Marc Rubin joins fellow new directors Christopher Dunn and Louis Miller

- PMLiVE

What can pharma learn from Olympic sports coverage?

Pharma companies should look to 'own' therapy areas in the way Sky Sports aims to own sports

Sanofi and Regeneron’s Zaltrap approved in US

First approval for colorectal cancer drug

- PMLiVE

GSK files melanoma drug candidates in EU and US

Submits BRAF inhibitor dabrafenib and MEK inhibitor trametinib

BMI Healthcare hires Doctors.net.uk to raise awareness of services

Online physician community will highlight BMI Healthcare services where treatments are unavailable on the NHS

Kai Gait returns to GSK as digital marketing director

He will be developing digital channel materials and services, built on customer insights

Generics account for 80 per cent of US prescriptions

IMS Health study finds savings of $193bn last year

Astellas to close US urology research facility

Work at Urogenix, North Carolina site will end by the end of the year

- PMLiVE

AstraZeneca UK launches Prostate Assistant mobile app

iPhone, iPad and Android app aims to help men with prostate cancer

Boehringer to manufacture Servier’s gevokizumab

Will produce inflammatory disease drug at its Biberach facility

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links